Gradientech is a Swedish in vitro diagnostics company specializing in ultra-fast antibiotic susceptibility testing (AST). Their flagship product, QuickMIC®, is designed to empower modern microbiology laboratories by delivering accurate minimum inhibitory concentration (MIC) values directly from positive blood cultures within 2-4 hours. The technology enables faster and more informed treatment decisions, improving healthcare and reducing the spread of antibiotic resistance.